Soluble TIM-3Biomarker1 paper studies itHuman trial1LatestVaccine·Oct 15Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adultsNon-randomized trial in 68 peopleInterventionsPaper
Vaccine·Oct 15Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adultsNon-randomized trial in 68 peopleInterventionsPaper